General Conditions

Use of this website is subject to the following General Conditions of Use. Please read them carefully. Do not use the website unless you agree to the conditions. Using or accessing this website implies full acceptance by the user of the conditions, in the version published on the website at the time of access.

PharmaMar is a global organisation comprising legal entities, business processes and management structures across multiple countries. This rights and privacy statement applies to all websites, domains, services, applications and products owned by PharmaMar and our subsidiaries (“PharmaMar sites and services”), except where a specific privacy policy or instruction for a particular PharmaMar program, product or service overrides or supplements this privacy statement

The content of this website is intended to be used solely for information purposes and, therefore, Pharma Mar, S.A. (hereinafter Pharma Mar) makes no warranties as to the accuracy or completeness of the information contained or referenced herein. Keep in mind that the materials contained in this website may not reflect the most recent information about the products and/or services offered by Pharma Mar. In addition, such materials may be modified, developed or updated without prior notice. Please note that some of the drugs described on this website are still in the clinical developmental phase and not yet available for prescription.

The user agrees to access the website and its content on its account and at its own risk. Pharma Mar may not be held liable for any errors or omissions in the website content or any other content accessed through the website. The User acknowledges that he/she accesses the Website and its content at his/her own risk. PharmaMar accepts no liability whatsoever for any errors or omissions in this Website or other content that may be accessed through it, and it accepts no liability whatsoever for any harm that might arise from, or be connected with, the use of the information contained on such websites. In particular, PharmaMar wishes to make it clear that any content about healthcare, illness and medical treatment contained on this Website is purely for informational purposes and should not, in any case, take the place of a consultation with a medical professional. Consequently, PharmaMar accepts no liability whatsoever for any decisions that the User may make based on the information about healthcare, illness and medical treatment contained in this Website or for any harm arising for the User or third parties as a result of actions based upon the information contained in this Website. Moreover, Pharma Mar assumes no liability whatsoever for any losses and damages that could result from or be connected with the use of the information contained in such websites.

The user undertakes to use the website solely and exclusively for personal purposes and, therefore, may not use it for business, access to and use of such website being the user’s responsibility.

The user undertakes to use the website in accordance with the provisions of the current legislation, these General Conditions, and the norms of good behavior, moral codes and public order.

As a service providing added value to visitors, Pharma Mar provides links to other websites.

Every effort has been made to carefully select websites that we believe are useful and meet our high standards. However, because websites change very rapidly, we cannot warrant these standards for all website links we provide, nor do we accept any liability whatsoever for the content of third-party websites.

Pharma Mar makes no warranties regarding the absence of viruses or other harmful elements that could cause damage or alterations to the website user’s computer system, electronic documents or files. Consequently, Pharma Mar may not be held liable for any losses or damages that such elements could cause the user or third parties.

Any changes in these General Conditions of Use will be promptly posted on this website.

Intellectual Property Rights

All industrial and intellectual property rights over all information contained on this site, graphic design, drawings, logos, images, indexes and html or JavaScript source code, are held by Pharma Mar (except for third-party content accessed by the user through hypertext links) and are protected by Spanish, European and international regulations regarding intellectual and industrial property.

All industrial and intellectual property rights over this website are legally reserved, and access to or use of this website by users may, in no way, be considered the grant of any license for use or right over any assets held or owned by Pharma Mar or the respective legitimate authors. Any reproductions, copies, distribution, conversions, public disclosures or other activities carried out with the information contained in this website, as well as with its design and the selection or form of presentation of the materials included therein, are prohibited unless expressly authorized by Pharma Mar or the respective legitimate author, regardless of the purpose or the medium used in such case. Any framing or third-party use of any other mechanisms that alter the design, original configuration or content of the Pharma Mar website is expressly prohibited.

In all cases, the website user must refrain from removing, altering, evading or tampering with any protection devices or security systems installed on the website.

Applicable Law and Jurisdiction

The present General Conditions of Use are subject to the Spanish legal system.
For the resolution of any dispute which may arise as a result of accessing the Pharma Mar website, the user and Pharma Mar hereby expressly agree to submit themselves to the Courts and Tribunals of the City of Madrid, waiving any other general or special jurisdiction to which they may entitled.

© 2015 PHARMAMAR. All rights reserved

Science & Innovation

Our strong commitment to oncology translational research along with our deep understanding of the marine biodiversity of our oceans is placing us at the head of marine biotechnology.

Oncology pipeline

PharmaMar develops and commercializes YONDELIS® in Europe and has three clinical-stage drug candidates under development for several types of solid and hematological cancers, Aplidin ®, Lurbinectedin, and PM184.

Newsroom

If you need information about the company, our clinical trials, corporate images or multimedia, visit our newsroom